Drugs / Zoredronic acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05755854 Background | May 2023 → Dec 2024 | hematologic disorder | Anhui Provincial Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zoredronic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05755854 ↗ |
| Route | Intravenous | “Intravenous zoredronic acid 50ug/kg” NCT05755854 ↗ |